Healthcare Industry News: neuromodulation
News Release - July 14, 2014
Intact Vascular, Inc. Hires Bruce Shook as President and Chief Executive OfficerWAYNE, Pa.--(Healthcare Sales & Marketing Network)--Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced that Bruce J. Shook is joining the Company as President and Chief Executive Officer and as a member of its Board of Directors. Mr. Shook, a highly experienced medical device executive, previously spent the past 11 years at Neuronetics, a medical device company he co-founded and led as its President and CEO.
Dr. Dennis Wahr, Chairman of the Board at Intact Vascular, welcomed Mr. Shook. "We are delighted to have Bruce at the helm. His wealth of successful operational experience in medical device companies is a prerequisite to expedite Intact’s growth to the next level of both product and clinical development.”
Mr. Shook said, "I am very impressed with what the Intact Vascular team has accomplished. They have developed an extraordinarily innovative approach to the treatment of peripheral vascular disease that holds significant promise to advance endovascular therapy beyond the current practice of stenting. Intact has exceptional assets and I am truly excited to be working with this team to improve patient care, offer customers novel solutions, and build value for our stakeholders.”
About Bruce Shook
Prior to joining Intact Vascular, Mr. Shook was President and CEO of Neuronetics, a privately held medical device company that develops and markets therapeutic neuromodulation products for psychiatric and neurologic diseases. Mr. Shook co-founded Neuronetics in 2003 and was responsible for all facets of the company’s operations. Prior to Neuronetics, Mr. Shook co-founded Neuron Therapeutics, a privately held company developing drug/device combination products for the treatment of traumatic CNS disorders. Prior to Neuron Therapeutics, Mr. Shook was President of Abiomed (ABMD), a publicly traded manufacturer of advanced cardiac assist technology, where he worked to bring the first ventricular assist device to the U.S. market and was responsible for all commercial operations. He has also held positions in engineering, clinical research and regulatory affairs with Cordis Corporation. Mr. Shook has thirty years of experience in the medical device industry including venture finance of early stage companies.
Mr. Shook holds advanced degrees in biomedical engineering and business administration from Columbia University and the MIT Sloan School of Management, respectively, and a B.S. degree in Chemical Engineering from Penn State University.
About Intact Vascular (www.intactvascular.com)
Intact Vascular is a privately held medical device company that develops minimally invasive peripheral vascular products. The Tack-It Endovascular System™ is designed to optimize peripheral balloon angioplasty results in the treatment of peripheral artery disease. This technology will offer physicians a new treatment option for treating peripheral artery disease. Intact Vascular is committed to developing safe and efficacious products for patients and for the physicians who use these products. Visit www.intactvascular.com for more information.
Source: Intact Vascular
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.